天美传媒

Atherosclerosis: 天美传媒 Access
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Wenjin Li

Amgen Biopharmaceutical Research & Development (Shanghai) Co., Ltd, Shanghai, China. 13F, Building 2, 4560 Jinke Road, Shanghai 201210 P.R. China

Biography

Wenjin Li is a member of Amgen Biopharmaceutical Research & Development (Shanghai) Co., Ltd.
Research interest:  Biophysics, Molecular simulations, statistical mechanics, enzymatic reactions, drug design.
Publications

Prevalence and Outcomes of Familial Hypercholesterolemia Patients in a Chinese Myocardial Infarction Cohort

Background and aims: Familial Hypercholesterolemia (FH) is an inherited metabolic disorder with increased LDL-C levels and coronary heart disease (CHD) risk. The prevalence of heterozygous FH is approximately 1:200 to 1:500 worldwide and higher in CHD populations. We aim to estimate the prevalence of FH and the incidence of recurrent cardiovascular... Read More»

Yan Gao, Hong Yin, Ying He, Jihua Wu, Siming Wang, Wenjin Li, Xi Li, Ouhong Wang, Mingqiang Zhang and Lixin Jiang

Research Article: Atheroscler 天美传媒 Access 2017, 2:114

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top